Catalyst Wire Dossier Catalyst Wire Dossier

Cytotoxic Lymphocytes (CTL) Based Prostate Cancer Therapy

· CytoVac A/S
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Cytotoxic Lymphocytes (CTL) Based Prostate Cancer Therapy, covering 2012-04-27 to 2012-04-27. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of a Cytotoxic Lymphocytes (CTL) Based Prostate Cancer Therapy [Phase 1]

See pricing